Cardene IV
CGMP Deviations
Yes — there is an active recall. 6 ongoing FDA recalls mention Nicardipine (14 total). Check the affected lots below.
Most common reason: Sterility / contamination (7 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Nicardipine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
CGMP Deviations
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Lack of Assurance of Sterility.
Failed Impurities/Degradation Specifications: Out of specification for organic impurities
Failed Impurities/Degradation Specifications: Out of specification for organic impurities
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Subpotent Drug and Failed Impurities/Degradation Specifications
Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpuridine Derivative (NPP-D)
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.